Blank Rome LLP advised ThinkEquity on the deal while Sheppard Mullin advised Hepion Pharmaceuticals, Inc.
ThinkEquity, a division of Fordham Financial Management, Inc., acted as underwriters’ counsel in connection with a $34.5M follow-on offering of common stock of Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis and liver disease. The transaction was completed on November 30, 2020.
The Blank Rome team was led by Brad Shiffman (Picture), Melissa Murawsky and Maria Carnicella.
The Sheppard Mullin team included partner Jeff Fessler and associate Justin Anslow. Partner Jing Liu assisted on IP matters.